News related to Zetia (Ezetimibe) and/or conditions it is approved for
Cholesterol Drug Zetia Doesn't Cut Heart Attack Risk: Study
Source: MedicineNet ezetimibe Specialty [2008.01.15]
Title: Cholesterol Drug Zetia Doesn't Cut Heart Attack Risk: Study
Category: Health News
Created: 1/15/2008 2:00:00 AM
Last Editorial Review: 1/15/2008
ezetimibe and simvastatin, Vytorin
Source: MedicineNet ezetimibe Specialty [2008.04.16]
Title: ezetimibe and simvastatin, Vytorin
Category: Medications
Created: 1/31/2005 10:17:00 PM
Last Editorial Review: 4/16/2008
Karo Bio: Successful Phase II Study Expands The Potential For Eprotirome In Dyslipidemia Treatment
Source: Cholesterol News From Medical News Today [2008.10.30]
Karo Bio (STO:KARO) has successfully completed a 10 week phase IIb study with eprotirome given to dyslipidemia patients undergoing treatment with the cholesterol absorption inhibitor ezetimibe. Eprotirome induced a statistically significant and clinically relevant lowering of serum LDL-cholesterol, triglycerides and lipoprotein(a) and was safe and well tolerated. Data show that eprotirome in combination with ezetimibe can become an important treatment option for patients with dyslipidemia.
|
